NEXGEN ENERGY LTD (NXE)       3.72  +0.22 (+6.29%)

3.72  +0.22 (+6.29%)

CA65340P1062 - Common Stock - After market: 3.76 +0.04 (+1.08%)


Fundamental Rating

4

Taking everything into account, NXE scores 4 out of 10 in our fundamental rating. NXE was compared to 380 industry peers in the Oil, Gas & Consumable Fuels industry. While NXE has a great health rating, but there are worries on its profitability. NXE is quite expensive at the moment. It does show a decent growth rate.




Profitability

Profitability Rating

1

The Piotroski-F score of NXE is 4.00. This is a neutral score and indicates average health and profitability for NXE.
NXE has negative profitability rations, so we won't be analyzing them here.

NXE's Return On Assets of -8.54% is worse than the rest of the industry. The industry average Return On Assets is 5.28%. 81% of the industry peers have a better Return On Assets.
VS Industry

ROA (-8.54%) VS Industry: 19% outperformed.

-63,651.82
767.41

Valuation

Valuation Rating

1

With a price book ratio of 5.55, NXE is valued correctly.
The Price/Earnings Ratio is negative for NXE. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NXE. No positive earnings are expected for the next year.
Compared to an average industry price book ratio of 1.61, NXE is valued more expensive than its industry peers. 89% of the companies listed in the same industry are valued cheaper.
VS Industry

Price/Book (5.55) VS Industry: 11% outperformed.

2,215.58
0.02

Growth

Growth Rating

4

The Earnings Per Share has grown by an impressive 67.44% over the past year.

NXE is expected to show quite a strong growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 11.55% yearly.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPSN/A N/A 67.44% 66.63% 33.21% 22.49% 11.55%
RevenueN/A N/A N/A N/A N/A N/A N/A

Health

Health Rating

8

NXE has a Current Ratio of 12.68. This indicates that NXE is financially healthy and has no problem in meeting its short term obligations.
The Current Ratio of NXE is much better than the industry average of 1.16. NXE has a better rating than 91% of its industry peers.
NXE has a Quick Ratio of 12.68. This indicates that NXE is financially healthy and has no problem in meeting its short term obligations.
NXE is one of the better placed companies in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.02. NXE has a better rating than 91% of its industry peers.

An Altman-Z score of 12.04 indicates that NXE is not in any danger for bankruptcy at the moment.
The Altman-Z score of NXE is much better than the industry average of 1.92. NXE has a better rating than 91% of its industry peers.
The Debt to Equity ratio of NXE is in line with the industry averages.
The Piotroski-F score of NXE is 4.00. This is a neutral score and indicates average health and profitability for NXE.
VS Industry

Debt/Equity (0.15) VS Industry: 60% outperformed.

150.19
0.00

Quick Ratio (12.68) VS Industry: 91% outperformed.

0.00
295.99

Current Ratio (12.68) VS Industry: 91% outperformed.

0.00
295.99

Altman-Z (12.04) VS Industry: 91% outperformed.

-110,323.97
12,865.15

Dividend

Dividend Rating

0

NXE does not give a dividend.

NXE Daily chart

NEXGEN ENERGY LTD3.72

NYSE:NXE (9/27/2022, 4:44:46 PM)+0.22 (+6.29%)

After market: 3.76 +0.04 (+1.08%)

Chartmill FA Rating
GICS Sector Energy
GICS IndustryGroup Energy
GICS Industry Oil, Gas & Consumable Fuels
Earnings (Last) 08-05 2022-08-05/bmo Earnings (Next) 11-03 2022-11-03
Ins Owners N/A Inst Owners 25.51%
Market Cap 1.78B Analysts 83.08
Valuation
PE N/A Fwd PE N/A
PEG (NY) N/A PEG (5Y) N/A
P/S N/A P/B 5.55
EV/EBITDA -43.35
Dividend
Dividend Yield N/A Dividend Growth N/A
DP N/A Ex-Date N/A
Growth
EPS 1Y 67.44% EPS 3Y N/A
EPS 5Y N/A EPS growth Q2Q 50%
EPS Next Y 66.63% EPS Next 2Y 33.21%
EPS Next 3Y 22.49% EPS Next 5Y 11.55%
Revenue growth 1Y N/A Revenue growth 3Y N/A
Revenue growth 5Y N/A Revenue growth Q2Q N/A
Revenue Next Year N/A Revenue Next 2Y N/A
Revenue Next 3Y N/A Revenue Next 5Y N/A
Health
Current Ratio 12.68 Quick Ratio 12.68
Altman-Z 12.04 F-Score 4
Debt/Equity 0.15
Profitability
ROA -8.54% ROE N/A
ROIC N/A ROICg N/A
PM N/A OM N/A
Asset Turnover N/A

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA